Pulmonx shares surge 30.68% intraday after securing $60M credit facility and unveiling next-gen catheter.

Pulmonx Corp. surged 30.68% intraday following the announcement of closing a $60 million credit facility, which provides liquidity to support growth initiatives, and the launch of its next-generation Chartis Precision XL catheter, enhancing precision in pulmonary procedures. The credit facility strengthens the company’s financial flexibility, while the new product underscores innovation in its core market, likely boosting investor confidence in long-term revenue potential. Both developments align with the sharp intraday rally, reflecting positive market sentiment toward Pulmonx’s strategic and operational advancements.